[an error occurred while processing this directive] | [an error occurred while processing this directive]
Study the dosimetric for whole breast irradiation with fixed field IMRT and helical tomotherapy
YANG Bo,LIU Zhi-kai, HOU Xiao-rong, PANG Ting-tian,LI Wen-bo, LIU bo, SUN Hong-chang,HU Ke,QIU Jie,ZHANG Fu-quan.
Department of Radiotherapy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730,China
Objective To compare the dosimetry difference between helical tomotherapy and fixed field IMRT for breast cancer radiotherapy after breast-conserving surgery. Methods Ten patients received radiotherapy after breast-conserving surgery were selected. For each patient, two treatment plans (FF-IMRT plan and HT plan) were designed with Eclipse and TomoTherapy. Same institutional dose-volume constraints for breast cancer were used in both techniques. Targets and organs at risk were compared with paired t-test for two planning. Results In comparison with the FF-IMRT planning, PTV coverage of HT plan group increased, Dmean became lower (P=0.000,0.002). the HI and CI were significantly higher for HT (P=0.001,0.023).Compared with the FF-IMRT plans, V5,V10,V20,V30,V40 and Dmean of the ipsilateral lung were reduced by about 28%,30%,35%,46%,61% and 32%(P=0.000),those of full lung were reduced by about 30%,28%,34%,46%,62% and 26%(P=0.000), those and Dmax of heart were reduced by about 57%,59%,71%,82%,91%,45% and 12%(P=0.000—0.002).The Dmean and Dmax of contralateral breast were higher by 0.9 Gy and 3.0 Gy (P=0.000,0.000) respectively, those of contralateral lung were higher by 0.42 Gy and 2.70 Gy (P=0.000,0.000) respectively. It takes significantly long time for the HT plans designed than FF-IMRT plan (11.98 min:5.96 min,P=0.000). Conclusions The HT planning improve the HI and CI of PTV, organs at risk can get equivalent or superior dose distribution compared with the FF-IMRT technology, but it is feasible for clinical applications in breast-conserving surgery as a new method.
YANG Bo,LIU Zhi-kai,HOU Xiao-rong et al. Study the dosimetric for whole breast irradiation with fixed field IMRT and helical tomotherapy[J]. Chinese Journal of Radiation Oncology, 2013, 22(5): 411-413.
YANG Bo,LIU Zhi-kai,HOU Xiao-rong et al. Study the dosimetric for whole breast irradiation with fixed field IMRT and helical tomotherapy[J]. Chinese Journal of Radiation Oncology, 2013, 22(5): 411-413.
[1]Lohr F, El-Haddad M, Dobler B, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys,2009,74:73-80. [2]Hurkmans C, Cho B, Damen E, et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol,2002,62:163-171. [3]Mackie T, Holmes T, Swerdloff S, et al. Tomotherapy:a new concept for the delivery of dynamic conformal radiotherapy. Med Phys,1993,20:1709-1720. [4]Pigno JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol,2008,26:2085-2092. [5]Graham MV, Purdy JA, Emami B, et al. Preliminary result of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol phys,1995,33:993-1000. [6]Schubert LK, Gondi V, Sengbusch E, et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol,2011,100:241-246. [7]Gyenes G, Gagliardi G, Lax I,et al. Evaluation of irradiated heart volumes in stage Ⅰ breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol,1997,15:1348-1353. [8]Unnithan J, Macklis RM. Contralateral breast cancer risk. Radiother Oncol,2001,60:239-246. [9]Meeks SL, Buatti JM, Bova FJ,et al. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys,1998,40:483-495. [10]Goddu SM, Yaddanapudi S, Pechenaya OL,et al. Dosimetric consequences of uncorrected setup errors in helical tomotherapy treatments of breast-cancer patients. Radiother Oncol,2009,93:64-70.